EUVIMEDEUVIMED entdecken
Open Access

The Purine Biosynthesis Repressor, PurR, Contributes to Vancomycin Susceptibility of Methicillin-resistant Staphylococcus aureus in Experimental Endocarditis

Yan Q Xiong, Yi Li, Mariya I Goncheva, Ahmed M Elsayed, Fengli Zhu, Liang Li, Wessam Abdelhady, Ronald S Flannagan, Michael R Yeaman, Arnold S Bayer, David E Heinrichs

The Journal of Infectious Diseases · 2024

DOI: 10.1093/infdis/jiad577 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2024. Verfasst von Yan Q Xiong und 10 weiteren Autor:innen. Beteiligte Einrichtung: The Lundquist Institute for Biomedical Innovation, Harbor-University of California Los Angeles Medical Center, Torrance, California, USA. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Bacterial Proteins, Staphylococcal Infections, Purines. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, CIHR, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Staphylococcus aureus is the most common cause of life-threatening endovascular infections, including infective endocarditis (IE). These infections, especially when caused by methicillin-resistant strains (MRSA), feature limited therapeutic options and high morbidity and mortality rates.

Methods

Herein, we investigated the role of the purine biosynthesis repressor, PurR, in virulence factor expression and vancomycin (VAN) treatment outcomes in experimental IE due to MRSA.

Results

The PurR-mediated repression of purine biosynthesis was confirmed by enhanced purF expression and production of an intermediate purine metabolite in purR mutant strain. In addition, enhanced expression of the transcriptional regulators, sigB and sarA, and their key downstream virulence genes (eg, fnbA, and hla) was demonstrated in the purR mutant in vitro and within infected cardiac vegetations. Furthermore, purR deficiency enhanced fnbA/fnbB transcription, translating to increased fibronectin adhesion versus the wild type and purR-complemented strains. Notably, the purR mutant was refractory to significant reduction in target tissues MRSA burden following VAN treatment in the IE model.

Conclusions

These findings suggest that the purine biosynthetic pathway intersects the coordination of virulence factor expression and in vivo persistence during VAN treatment, and may represent an avenue for novel antimicrobial development targeting MRSA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Methicillin-Resistant Staphylococcus aureusBacterial ProteinsStaphylococcal InfectionsPurinesAnti-Bacterial AgentsVancomycinRepressor ProteinsEndocarditis, BacterialAnimalsVirulence FactorsMiceGene Expression Regulation, BacterialDisease Models, AnimalMicrobial Sensitivity TestsHumans

Stichwörter der Autor:innen

MRSAVAN persistenceand endocarditispurine biosynthesis

Substanzen

Bacterial ProteinsPurinesAnti-Bacterial AgentsVancomycinRepressor ProteinsPurR protein, BacteriaVirulence Factorspurine

Autor:innen und Institutionen

  • The Lundquist Institute for Biomedical Innovation, Harbor-University of California Los Angeles Medical Center, Torrance, California, USA.
  • Department of Medicine, Division of Infectious Diseases, Harbor-University of California Los Angeles Medical Center, Torrance, California, USA.
  • David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.
  • Department of Microbiology and Immunology, University of Western Ontario, London, Ontario, Canada.
  • Department of Medicine, Division of Molecular Medicine, Harbor-University of California Los Angeles Medical Center, Torrance, California, USA.

Förderung

  • NIAID NIH HHS
  • CIHR
  • NIH HHS
  • National Institutes of Health
  • Canadian Institutes of Health Research

Zitieren

APA

Xiong, Y. Q., Li, Y., Goncheva, M. I., Elsayed, A. M., Zhu, F., Li, L., Abdelhady, W., Flannagan, R. S., Yeaman, M. R., Bayer, A. S., & Heinrichs, D. E. (2024). The Purine Biosynthesis Repressor, PurR, Contributes to Vancomycin Susceptibility of Methicillin-resistant Staphylococcus aureus in Experimental Endocarditis. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiad577

Vancouver

Xiong YQ, Li Y, Goncheva MI, Elsayed AM, Zhu F, Li L, et al. The Purine Biosynthesis Repressor, PurR, Contributes to Vancomycin Susceptibility of Methicillin-resistant Staphylococcus aureus in Experimental Endocarditis. The Journal of Infectious Diseases. 2024. doi:10.1093/infdis/jiad577

BibTeX
@article{Xiong2024,
  author = {Xiong, Yan Q and Li, Yi and Goncheva, Mariya I and Elsayed, Ahmed M and Zhu, Fengli and Li, Liang and Abdelhady, Wessam and Flannagan, Ronald S and Yeaman, Michael R and Bayer, Arnold S and Heinrichs, David E},
  title = {The Purine Biosynthesis Repressor, PurR, Contributes to Vancomycin Susceptibility of Methicillin-resistant Staphylococcus aureus in Experimental Endocarditis},
  journal = {The Journal of Infectious Diseases},
  year = {2024},
  doi = {10.1093/infdis/jiad577}
}
Kostenlos starten →